Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medirom Healthcare Technologies (MRM) Cash & Current Investments (2019 - 2024)

Medirom Healthcare Technologies has reported Cash & Current Investments over the past 6 years, most recently at $2.2 million for Q4 2024.

  • Quarterly results put Cash & Current Investments at $2.2 million for Q4 2024, up 145.58% from a year ago — trailing twelve months through Dec 2024 was $2.2 million (up 145.58% YoY), and the annual figure for FY2024 was $2.2 million, up 145.58%.
  • Cash & Current Investments for Q4 2024 was $2.2 million at Medirom Healthcare Technologies, up from $898754.4 in the prior quarter.
  • Over the last five years, Cash & Current Investments for MRM hit a ceiling of $4.5 million in Q4 2022 and a floor of $233356.0 in Q4 2021.
  • Median Cash & Current Investments over the past 5 years was $898754.4 (2023), compared with a mean of $1.6 million.
  • Biggest five-year swings in Cash & Current Investments: surged 1816.89% in 2022 and later crashed 79.91% in 2023.
  • Medirom Healthcare Technologies' Cash & Current Investments stood at $311256.6 in 2020, then dropped by 25.03% to $233356.0 in 2021, then surged by 1816.89% to $4.5 million in 2022, then crashed by 79.91% to $898754.4 in 2023, then soared by 145.58% to $2.2 million in 2024.
  • The last three reported values for Cash & Current Investments were $2.2 million (Q4 2024), $898754.4 (Q4 2023), and $4.5 million (Q4 2022) per Business Quant data.